The DNA fragments of omph and ompa were amplified by PCR from avian Pasteurella multocida. These fragments were inserted into pCDNA3.1(+) vector to construct DNA vaccines as follows: pCDNA-OMPH (pOMPH), pCDNA-OMPA (pOMPA) and pCDNA-OMPH/OMPA (pOMPHA). The three plasmids were transfected into SP2 /0 cell in vitro. Expression of target genes were analyzed by indirect immunofluorescence. Four-weeks-old chickens were vaccinated with these DNA vaccines. The chickens injected with attenuated vaccine were positive control and the chickens injected with pCDNA3.1(+) were negative control. The serum antibodies were tested. Immunized chickens were challenged with virulent of avian Pasteurella multocida, the protection rate were counted. Results of ELISA showed the levels of antibodies in fusion DNA group were equivalent to group of attenuated vaccine, and significantly higher than the two single DNA groups (P<0.05). All the DNA vaccines could provide partial protection for chickens after the challenge. The protection rate of fusion DNA vaccine was higher than the attenuated vaccine, and the latter higher than the two single DNA vaccines. The results indicated DNA vaccines especially fusion DNA vaccines provide
Introduction
Fowl cholera, caused by avian Pasteurella muhocida, is a contagious disease of poultry and fowl and is widely distributed in many countries. It seriously endanger the stable development of poultry industry.
The mjor control measures against this disease is drug treatment, particularly antibiotics, e.g. streptomycin sulfate, olaquindox etc. However, the disease is easy to relapse after drug withdrawal, the pathogen susceptible to drug resistance after long-term medication, and also may produce significant toxic effects to avian. Laying rate may be significant decrease in layers and drug residue in broilers. Therefore, it's necessary to immunoprophylaxis with available vaccines for fundamentally control the prevalence of fowl cholera.
Currently, the vaccines for prevention of fowl cholera include attenuated vaccine and Inactivated vaccine. The former was the most widely studied in the field of poultry attenuated vaccine research in china and achieved the development of peak in 1980s [1] . Nevertheless, the antigenic structure of avian Pasteurella muhocida is complicated, and prones to mutation. The protective effect achieved through commercial live vaccine is not ideal. The attenuated vaccine has some shortcomings, for instance, shortterm immunoprote--ction, poor protective effect and the possibility of excretion virion. Residual virulence may lead to degression of laying rate, and the disease may be outbreak after incorrect use [2] . The immunological effect of inactivated vaccine not as good as live vaccine, therefore, the inactivated vaccine rarely applied.
DNA vaccine, which has the advantages of convenient preparation, low cost, easy to preserve, is currently the subject of intense investigation in the field of vaccine research [3] . DNA vaccines can prodive prolonged antigen expression, leading to boost of immune response and induce memory response against infection. So, DNA vaccines are known as the third revolution in the history of vaccine development. A variety of DNA vaccines against infectious diseases have been studied, such as AIDS, tuberculosis and so on [4, 5] . In this study, we used the protective antigen genes omph and ompa of avian Pasteurella muhocida as the basis for construction of the monovalent and fusion DNA vaccines. Then chickens were vaccinated with these DNA vaccines, and the levels of antibodies and efficacy of protection were tested. The aim of this study was laying a foundation for further research and development of vaccines against Pasteurella muhocida infection.
Materials and Methods

Bacterial strains, vaccine and cells
Pasteurella muhocida-CVCC474 strain was purchased from Chinese Institute of Veterinary Drug Control (IVDC). attenuated live vaccine was purchased from Qilu Animal Health Products Co., Ltd. competent cell DH5 , mouse myeloma cell SP2/0 were conserve in the laboratory of He Nan university of science and technology in china.
PCR amplification
Primes were designed according to the nucleotide sequences of the omph and ompa genes of Pasteurella muhocida strain Pm-17 and 95010872 respectively. Table. 1. lists the primer sequences.
The target gene fragments were amplified using the genomic DNA as a template. The omph gene was amplified using primer pairs a b and a c, resulting in fragment A (containing the initiation and termination codons) and fragment B (containing the initiation). The ompa gene was amplified using primer pairs d e and f g, resulting in fragment C (containing the initiation and termination codons) and fragment D (containing the termination codons). 
The KpnI recognition sequence is underlined and initiator is concluded; b, g: The EcoRI recognition sequence is underlined and termination codon is concluded; c, e, f: The BamHI recognition sequence is underlined and the termination codon is concluded in e
Construction of recombinant plasmids
The purified gene fragments A and C were digested with KpnI/EcoRI and KpnI/BamHI, respectively. Then they were ligated into pcDNA3.1(+). Competent Escherichia coli DH5 was transformed with the two recombinant plasmids. The plasmids were extracted and identified with restriction enzymes. The positive plasmids were named pcDNA3.1(+)-omph (pcH) and pcDNA3.1(+)-ompa (pcA), respectively. Fragment B was cloned into the KpnI/BamHI site of pcDNA3.1(+), followed by the insertion of fragment D into BamHI /EcoRI, resulting in the recombinant pasmid pcDNA3.1(+)-omph-ompa (pcHA). The plasmids were prepared on a large scale using the alkaline lysis method, and the plasmid preparations were adjusted to 1 g/ l using phosphate-buffered saline (PBS: 0.01M, pH 7.2) for futher experiments.
Preparation of anti-serum
Rabbit anti-avian Pasteurella muhocida Omps serum was prepared as follows: Omps, extracted by supersonic split, was misced et fiat vaccine with vash oil and immunized rabbits. The rabbits were injected with 2mg of the above vaccine by subcutaneously, three times at 2-week intervals. The blood samples were drawn from the rabbits, serum was obtained and stored in -20 refriger tor.
Expression of recombinant plasmids in vitro
One day before transfection, mouse myeloma SP2/0 cells at logarithmic growth phase were seeded into 24-well plates and grown at 37 C, 5%CO 2 until 80% confluency. They were then transfected with 0.8μg of pcH, pcA, pcHA and pcDNA3.1(+) using 2μl of Lipofectamine 2000 followed by indirect immunofluorescent testing after 72h [6] . Briefly, the cells were fixed with methanol/acetone for 20 min at room temperature, followed by addition of 200 l rabbit anti-Omps polyclonal antibody (1:40 dilution), and incubated in a moist chamber for 1 h at 37 C. Next, 200 μl fluorescein isothiocyanate (FITC)-labelled goat anti-rabbit IgG (1:100 dilution) containing 1% Evans blue was added; the samples were incubated in a moist chamber for 1 h at 37 C, and were then observed in a drop of basic glycerine under an inverted microscope to visualize blue-green fluorescence in SP2/0 cells.
Immunization of chickens
Nonimmune chickens (n = 75), 1 day old, were purchased from the laboratory animal facility of henan province in China. DNA vaccination were carried out when the chickens were bred to 4 weeks of age. The animals were randomly assigned to immunization groups containing 15 chickens each. The chickens were immunized with 200μg of the DNA vaccines by intramuscular injection for each DNA immunization group. Chickens in the negative control groups were given empty vector pcDNA3.1. The animals in each of the above groups were immunized three times at 2-week intervals. In the positive control group, chickens were inoculated with 0.5ml attenuated live vaccine of avian Pasteurella muhocida at the time of initial vaccination.
Serum antibody levels
After immunization, blood samples were drawn from the chickens and serum specimens were isolated. The serum antibody titers were determined using indirect enzyme-linked immunosorbent assay (ELISA) [7] . Briefly, ELISA microtiter plates were coated with 10 9 cfu mL of avian Pasteurella muhocida suspension, followed by blocking nonspecific binding using 100 μl of 5% bovine serum albumin for 2 h. This was followed by the addition of 50 l of serum (1:100 dilution), and the samples were incubated in a moist chamber at 37 C for 1.5 h. The plates were washed three times with PBST and rabbit anti-chicken IgG-Horseradish peroxidase (HRP) was added and incubated at 37 C for 1.5 h. Plates were washed three times with PBST, then 50μl Ortho-phenylene diamine (OPD, Sigma) was added and incubated for 10 min. Enzyme activity was stopped by adding an equal volume of 2M H 2 SO 4 , and the absorption was measured at 492 nm. Antibody titers were determined for up to 6 weeks before challenge.
Challenge
Every chicken was challenged 2 weeks after 3 rd DNA immunization with the virulent strain CVCC474 (5LD50/one chicken) by intramuscular. The chickens were reared for two weeks, the survival number and protection rate were counted.
Statistical analysis
The data from the experiments were expressed as mea standard deviation (S.D.). Statistical analysis was conducted with SAS software. Analysis of variance was used to determine the significance of differences in means between the experimental groups. Difference with P 0.05 were considered significant.
Results
Expression of recombinant plasmids in vitro
SP2/0 cells transfected with recombinant plasmids pcH, pcA and pcHA showed blue-green fluorescence under an inverting microscope, demonstrating that avian Pasteurella muhocida genes, omph, ompa and omph-ompa were transfected into SP2/0 cells and the cells expressed the target proteins. In contrast, the SP2/0 cells transfected with pcDNA3.1(+) did not fluoresce (Fig. 1) . 
The antibodies induced by DNA vaccination
Sera collected 1-6 weeks after the first vaccination were assayed for the presence of specific antibodies by indirect ELISA. As shown in Fig.2 ., strong humoral responses had been generated by the DNA vaccines and attenuated live vaccine. After immunization, the serum antibody levels in the attenuated live vaccine and pcHA-groups were significantly higher than those in pcH-and pcA-vaccinated groups (P<0.05) and in the negative control groups(P<0.01). There are no difference in the antibody levels among the attenuated live vaccine and pcHA-vaccinated groups (P>0.05), though the former was slightly higher than the latter two. In addition, the serum antibody levels in the two monogenic DNA vaccines groups were significantly higher than those in pcDNA3.1(+) groups (P<0.01). 
Challenge study
Groups of chickens were challenged with live virulent avian Pasteurella muhocida CVCC474 strain 2 weeks after last immunization. Survival number and protection rate were counted till 14days (Table. 2.). The mortality of chickens receiving pcDNA3.1(+) were almost 93.3% after challenge. The protection rate in the attenuated live vaccine and pcHA-vaccinated groups were higher in the pcH-and pcA-vaccinated groups (P<0.05). The survival of chickenls immunized with pcHA (73.3%) were lower than those in the chickens immunized with attenuated live vaccine (80%) 
Discussion
Outer membrane proteins of varied pathogenic bacteria have been recognised as immunodominant antigens [8, 9] .The in-depth study about outer membrane proteins will help clarify their role in the pathogenesis and immune response of bacteria. Confer et al. vaccinated animals with Pasteurella muhocida and tested the level of serum antibodies by ELISA, and detected that 6 anti-Omps antibodies had relationships with the immune protection, and those antibodies could enhance the phagocytosis of macrophage and active complement. Their research indicated Omps of Pasteurella muhocida plays an important role in resistance to infection [10] . Out membrane proteins of Pasteurella muhocida comprises arch-protein and small protein, OmpH, OmpA, Oma87 and PlpB protein were the former.
OmpH is the supr-microbore-protein of Pasteurella muhocida and the protective antigen. Luo et al. extracted OmpH protein, which had porin activity, and demonstrated that immunization of purified native OmpH was able to confer the protection of chickens from fowl cholera by challenge-exposure with parental strain X-73, the level of protection was equivalent to that achieved using whole cell after challenge. But the recombinant OmpH of strain X-73 induced little protection against challenge-exposure of parental strain [11] . Further research showed that OmpH proteins from different serotypes were highly homologous and had cross-protection [12] . OmpA, also called heat-modifiable protein, is a protective antigen of Pasteurella muhocida too. Experimental animal mortality was descend obviously after immunized with the monoclonal antibody against OmpA, which was prepared by Lu et al [13] . The same as OmpH, the research of Rimler showed OmpA proteins of Pasteurella muhocida had cross-protection among ifferent serotypes [14] . However, Some research results showed the protective effects provided by OmpA protein were not ideal, although it could induce high level immune response [15] . So, the immunological effect created by OmpA protein of Pasteurella muhocida has not yet conclusive.
Humoral immunoresponse is an important factor in resistance to avian Pasteurella muhocida infection. In this study, we detected the levels of antibodies induced by the DNA vaccines, and found that the abilities to stimulate humoral immunoresponse of the fusion DNA vaccines were correspond to that of attenuated live vaccine and surpass the two monovalent DNA vaccines. The Challenge experiment is one of the important index to evalue the protective efficacy of vaccines. In this study, chickens immunized with various vaccines were challenged with virulent avian Pasteurella muhocida. All the DNA vaccines could confer the protection on experiment animals. Among these DNA vaccines, the fusion DNA vaccine showed promise, and provides a valuable reference for the design of future DNA vaccines against fowl cholera.
